US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Pharmaceutical ETF

108.06

-0.0800-0.07%

Post-market: 108.060.00000.00%19:30 EDT

Volume:272.52K

Turnover:29.38M

Market Cap:1.01B

PE:87.56

High:108.33

Open:108.14

Low:107.29

Close:108.14

52wk High:118.00

52wk Low:90.60

Shares:9.39M

Float Shares:9.39M

Volume Ratio:0.61

T/O Rate:2.90%

Dividend:2.18

Dividend Rate:2.02%

EPS(TTM):1.23

EPS(LYR):0.7765

ROE:--

ROA:--

PB:--

PE(LYR):139.17

Loading ...

Overview Company News Filings

Sanofi, Regeneron's Dupixent Successors Might Fall Short of Rivals

Novartis, Abogen Sign RNA Licensing Agreement Worth up to $7.2 Billion

MT Newswires Live

Novartis Strikes up to $7.8 Billion mRNA Deal with China's Abogen

Merck & Co. Inc. Stock Outperforms Competitors Despite Losses on the Day

Sector Update: Healthcare

MT Newswires Live

AbbVie (ABBV) Stock May Be 41% Undervalued On FDA Approval

Simply Wall St.

Trump Medicare Drug Pricing Model May Apply to Only Four Companies After Exemptions

Merck's Tulisokibart Data From Hidradenitis Suppurativa Trial Looks Solid, UBS Securities Says

MT Newswires Live

Eli Lilly's Obesity Data Support Broader Portfolio Beyond Tirzepatide, UBS Says

MT Newswires Live

Eli Lilly (LLY) Ends Cancer Development Deal with Foghorn Therapeutics

AbbVie Says Phase 3 Trials Show Rinvoq Vitiligo Repigmentation Gains Extend to Week 76

Abbvie - Phase 3 Studies Show Continued Repigmentation with Rinvoq Through Week 76

THOMSON REUTERS

Abbvie - Rinvoq Plus NB-Uvb Shows Higher Repigmentation than Rinvoq Alone

THOMSON REUTERS

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (OtherSNYNF), Sagimet Biosciences, Inc. Class A (SGMT) and Eli Lilly & Co (LLY)

AbbVie to Host Third-Quarter 2026 Earnings Call Webcast

Foghorn Therapeutics Slashes Jobs After Ending Cancer Drug Trials with Ely Lilly

Jefferies Adjusts Price Target on Merck & Co to $177 From $175, Keeps Buy Rating

MT Newswires Live

InflaRx Appoints Gabriela Alperovich as SVP, Global Head of Clinical Development

Lilly Says Foundayo Cuts Predicted 10-Year Type 2 Diabetes Risk 57% in Attain-1 Post-Hoc Analysis

Eli Lilly - Foundayo 17.2 Mg Associated with 57% Reduction in Diabetes Risk, 18% in Cardiovascular Risk Versus Placebo

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/PPH/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPH\",,,,,undefined,":{"symbol":"PPH","market":"US","secType":"STK","nameCN":"VanEck Pharmaceutical ETF","latestPrice":108.06,"timestamp":1790971200000,"preClose":108.14,"halted":0,"volume":272520,"hourTrading":{"tag":"盘后","latestPrice":108.06,"preClose":108.06,"latestTime":"19:30 EDT","volume":40,"amount":4324.26,"timestamp":1790983847593,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0007397817643794922,"floatShares":9388138,"shares":9388138,"eps":1.234146,"marketStatus":"Market Closed","change":-0.08,"latestTime":"10-02 16:00:00 EDT","open":108.14,"high":108.325,"low":107.29,"amount":29378216.0286,"amplitude":0.009571,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":1.234146,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":108.14,"sharesOutstanding":11938138,"nav":108.04699,"aum":1014360012.4,"dividendRate":0.020154,"bidAskSpread":0.000353,"preHourTrading":{"tag":"盘前","latestPrice":108.61,"preClose":108.14,"latestTime":"08:05 EDT","volume":7,"amount":766.507798,"timestamp":1790942726383,"change":0.47,"changeRate":0.004346,"amplitude":0.021052},"postHourTrading":{"tag":"盘后","latestPrice":108.06,"preClose":108.06,"latestTime":"19:30 EDT","volume":40,"amount":4324.26,"timestamp":1790983847593,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6059622308904572,"impliedVol":0.2234,"impliedVolPercentile":0.8008},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPH\",,,,,undefined,":{"symbol":"PPH","floatShares":9388138,"roa":"--","roe":"--","lyrEps":0.776475,"volumeRatio":0.6059622308904572,"shares":9388138,"dividePrice":2.1778,"high":108.325,"amplitude":0.009571,"preClose":108.14,"low":107.29,"week52Low":90.6,"pbRate":"--","week52High":118,"institutionHeld":0,"latestPrice":108.06,"eps":1.234146,"divideRate":0.020154,"volume":272520,"delay":0,"ttmEps":1.234146,"open":108.14,"prevYearClose":103.17,"prevWeekClose":111.35,"prevMonthClose":109.47,"prevQuarterClose":109.47,"fiveDayClose":111.35,"twentyDayClose":115.77,"sixtyDayClose":109.63},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PPH\",params:#limit:5,,,undefined,":[{"date":"2026-10-01","symbol":"PPH","amount":0.36,"announcedDate":"2026-09-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-10-01","defaultRemindTime":1790861400000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-06","payableDate":"2026-10-01","currency":"USD","dateTimestamp":1790827200000,"payDate":"2026-10-06"},{"date":"2026-07-01","symbol":"PPH","amount":0.6248,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-01","defaultRemindTime":1782912600000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-07","payableDate":"2026-07-01","currency":"USD","dateTimestamp":1782878400000,"payDate":"2026-07-07"},{"date":"2026-04-01","symbol":"PPH","amount":0.8441,"announcedDate":"2026-03-31","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-01","defaultRemindTime":1775050200000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-07","payableDate":"2026-04-01","currency":"USD","dateTimestamp":1775016000000,"payDate":"2026-04-07"},{"date":"2025-12-29","symbol":"PPH","amount":0.3106,"announcedDate":"2025-12-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-29","defaultRemindTime":1767018600000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-29","currency":"USD","dateTimestamp":1766984400000,"payDate":"2025-12-31"},{"date":"2025-10-01","symbol":"PPH","amount":0.3931,"announcedDate":"2025-09-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-10-01","defaultRemindTime":1759325400000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-06","payableDate":"2025-10-01","currency":"USD","dateTimestamp":1759291200000,"payDate":"2025-10-06"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PPH\",market:\"US\",,,undefined,":[{"executeDate":"2016-10-03","recordDate":"2016-10-05","paymentDate":"2016-10-07","value":0.2148,"currency":"USD"},{"executeDate":"2016-12-28","recordDate":"2016-12-30","paymentDate":"2017-01-04","value":0.1449,"currency":"USD"},{"executeDate":"2017-04-03","recordDate":"2017-04-05","paymentDate":"2017-04-07","value":0.4651,"currency":"USD"},{"executeDate":"2017-07-03","recordDate":"2017-07-06","paymentDate":"2017-07-10","value":0.304,"currency":"USD"},{"executeDate":"2017-10-02","recordDate":"2017-10-03","paymentDate":"2017-10-06","value":0.221,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PPH\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672137097","title":"Sanofi, Regeneron's Dupixent Successors Might Fall Short of Rivals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672137097","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672137097?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:35","pubTimestamp":1790933700,"startTime":"0","endTime":"0","summary":"0934 GMT - Sanofi and Regeneron Pharmaceuticals' potential successors to blockbuster medicine Dupixent might lag behind rival drugs Pfizer and AbbVie are developing, Citi analysts say in a research note. The new experimental drugs Sanofi and Regeneron will jointly develop under their alliance focus solely on extending the dosing interval of Dupixent without compromising efficacy or tolerability, but there is no expectation of a superior performance, Citi says. This suggests those medicines might struggle to compete with Pfizer's tilrekimig and AbbVie's zumilokibart, both of which have shown potential for better efficacy in midstage trials, according to Citi. Moreover, it might be challenging for Sanofi and Regeneron to get reimbursement for those drugs from healthcare payers after copycat versions of Dupixent become available, the analysts add. Sanofi shares fall 3.4%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1244550577.SGD","TRUH","BK4585","JDOC","LU0029864427.USD","LU1057294990.SGD","VHT","SNY","BK4599","RXL","LU0211327993.USD","ABBV","IYH","MEDX","IXJ","LU0069063385.USD","LU0949170772.SGD","LU1720051108.HKD","AGNG","PPH","TBXU","FHLC","LU1917777945.USD","GLAM","LU2112291526.USD","LU0417517546.SGD","LU2347655073.USD","LU0795875169.SGD","LU2133065610.SGD","PJP","LU0053666078.USD","IBB","IE00BJT1NW94.SGD","LU1883839398.USD","PFE","LU0965509283.SGD","REGN","LU0158827948.USD","SNYNF","LU1037948541.HKD","IBBQ","LU0203347892.USD","LU0098860793.USD","XLV","OZEM","LU2106854487.HKD","LU0128525929.USD","FTXH","BBH","LU0057025933.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672608718","title":"Novartis, Abogen Sign RNA Licensing Agreement Worth up to $7.2 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2672608718","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672608718?lang=en_us&edition=fundamental","pubTime":"2026-10-02 16:33","pubTimestamp":1790930014,"startTime":"0","endTime":"0","summary":"Novartis  entered into a licensing and option agreement with Abogen Biosciences to advance RNA-encoded therapeutics, Abogen said Friday.Under the agreement, Novartis receives an exclusive worldwide license to lead autoimmune asset ABO2203 along with options for future RNA platform programs, Abogen Biosciences said.Abogen Biosciences will receive $575 million upfront and remains eligible for up to $7.2 billion in milestone payments plus potential sales royalties, it said.The lead drug candidate uses mRNA to produce immune system cell engagers inside the body to clear B cells in patients with autoimmune diseases, the company added.Abogen said the agreement also gives Novartis options on other potential drug programs using its RNA technology, expanding the potential application of the platform beyond vaccines.The transaction remains subject to customary closing conditions, including required regulatory clearances.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MEDX","LU0070302665.USD","LU0208291251.USD","IE00BJT1NW94.SGD","BK4585","BK4588","BK4007","BK4578","LU0320765489.SGD","IE0002141913.USD","BK4532","IE00BFTCPJ56.SGD","IE0009355771.USD","IE00B4R5TH58.HKD","LU0211331839.USD","NVS","IE00BJJMRZ35.SGD","PPH","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672790916","title":"Novartis Strikes up to $7.8 Billion mRNA Deal with China's Abogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2672790916","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672790916?lang=en_us&edition=fundamental","pubTime":"2026-10-02 15:57","pubTimestamp":1790927874,"startTime":"0","endTime":"0","summary":"UPDATE 3-Novartis strikes up to $7.8 billion mRNA deal with China's AbogenOct 2 (Reuters)-Chinese biotech company Abogen said on Friday it has signed a licensing deal worth up to $7.8 billion with Nov","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nL4N45O0D4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","BMED","GNOM","LU0098860793.USD","03165","RXL","SG9999015358.SGD","TRUH","XLV","IXJ","IHE","LU0823416689.USD","PPH","LU0011850046.USD","WDNA","LU0920783379.SGD","MRNA","LU1291159041.SGD","LU1989771016.USD","HRTS","LU0070302665.USD","LU0203347892.USD","IE00BLSP4239.USD","IE00BKPKM643.USD","LU0757432116.USD","LU1814569148.SGD","SGXZ57979304.SGD","LU1430594728.SGD","LU0976567544.SGD","MRNY","GDOC","FTXH","LU2106854487.HKD","IDNA","AZN.UK","LU1051770623.HKD","LU1880407132.USD","FHLC","PAWZ","BK4007","VHT","LU0171293334.USD","LGHT","IYH","LU1261432733.SGD","LU2112291526.USD","JDOC","LU0162691827.USD","MRK","LU0942090050.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672762679","title":"Merck & Co. Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2672762679","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672762679?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:33","pubTimestamp":1790886780,"startTime":"0","endTime":"0","summary":"DJ Merck & Co. Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Merck & Co. Inc.  slipped 1.03% to $143.81 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.19% to 7,666.45 and the Dow Jones Industrial Average  rising 0.04% to 50,926.56.This was the stock's second consecutive day of losses.Merck & Co. Inc. closed 8.35% short of its 52-week high of $156.92, which the company reached on August 25th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson  fell 2.30% to $258.66, Pfizer Inc.  fell 1.40% to $28.12, and Eli Lilly & Co.  fell 0.62% to $1,149.85.Trading volume  remained 2.2 million below its 50-day average volume of 10.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 1, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B1BXHZ80.USD","LU0965509283.SGD","LU0266013472.USD","LU0511384066.AUD","IE00BBT3K403.USD","IXJ","LU0432979614.USD","LU1116320901.HKD","LU2324357040.USD","LU1037948897.HKD","LU0098860793.USD","LU0823416689.USD","LU1116320737.USD","IE00BJJMRZ35.SGD","SGXZ57979304.SGD","IE0002141913.USD","LU1291159041.SGD","IE00BSNM7G36.USD","LU0162691827.USD","LU1162221912.USD","SG9999001176.SGD","LU0289739699.SGD","LU2491049909.HKD","BK4585","BMED","IE00BJT1NW94.SGD","LU1974910355.USD","LU1035773651.USD","LU1023059063.AUD","LU0211331839.USD","LU0942090050.USD","LU0689626769.HKD","LU0203345920.USD","BK4007","LU1066053197.SGD","LU1934455194.USD","LU0289961442.SGD","LU0868494617.USD","IYH","LU2361044949.HKD","LU0861579265.USD","LU1061106388.HKD","LU1934455277.USD","LU0320765646.SGD","LU2106854487.HKD","SG9999014542.SGD","LU2361045086.USD","SG9999013999.USD","JDOC","LU0070302665.USD","LU1069347547.HKD","IE00B4R5TH58.HKD","GDOC","LU1941712264.USD","VHT","LU2112291526.USD","BK4516","IE00B2B36J28.USD","LU0069063385.USD","LU0057025933.USD","IE0009355771.USD","TRUH","LU0234572021.USD","BK4588","LU0980610538.SGD","LU0006306889.USD","LU1066051498.USD","SG9999014575.USD","HRTS","LU0320765489.SGD","LU1430594728.SGD","LU1093756168.USD","SG9999001176.USD","LU2125154935.USD","LU0130517989.USD","LU0203347892.USD","LU1093756325.SGD","LU2491050071.SGD","LU1934455863.HKD","LU0122379950.USD","IE00BLSP4452.SGD","LU1066051225.USD","LU1057294990.SGD","LU0477156953.USD","LU0238689110.USD","LU2360032135.SGD","LU1923622614.USD","LU2023250843.SGD","LU1037948541.HKD","SG9999001440.SGD","LU1201861249.SGD","SG9999014567.USD","LU0265550359.USD","LU1699723380.USD","LU0472753341.HKD","LU2461242641.AUD","LU2125154778.USD","FTXH","LU1032466523.USD","LU0965509101.SGD","LU2468319806.SGD","LU1571399168.USD","LU1585245621.USD","SG9999014559.SGD","SG9999002224.SGD","FHLC","LU0124676726.USD","LU0058720904.USD","LU2491050154.USD","MRK","IE000M9KFDE8.USD","BK4534","IE00BLSP4239.USD","LU2433249047.HKD","LU0648001328.SGD","LU1917777945.USD","LU2089984988.USD","LU0289739343.SGD","PPH","LU0965509010.AUD","RXL","LU0868494708.USD","LU1929549753.HKD","LU1989772923.USD","LU1989771016.USD","LU2125909593.SGD","PAWZ","LU1066051811.HKD","LU1941712348.USD","IHE","IE00BFTCPJ56.SGD","LU2361044865.SGD","LU0859254822.USD","LU2357627491.SGD","LU0265550946.USD","BK4533","LU2125909247.SGD","SG9999002232.USD","XLV","BK4550","LU0072461881.USD","LU0985320562.USD","LU0965508806.USD","LU1983299246.USD","LU2023250504.SGD","IE00BN8TJ469.HKD","LU0106261372.USD","LU1989772840.SGD","SG9999015358.SGD","LU0208291251.USD","SG9999015341.SGD","LU0130102774.USD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672783761","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2672783761","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672783761?lang=en_us&edition=fundamental","pubTime":"2026-10-02 03:29","pubTimestamp":1790882992,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined late Thursday afternoon, with the NYSE Healthcare Index falling 1% and the State Street Health Care Select Sector SPDR ETF  dropping 1.1%.The iShares Biotechnology ETF  shed 1.6%.In corporate news, Foghorn Therapeutics  and Eli Lilly  have decided not to advance FHD-909 into the clinical development expansion phase after reviewing clinical data from a phase 1 dose escalation trial. Foghorn shares fell 16%, and Lilly was down 0.2%.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0210536198.USD","LU2462591350.SGD","LU2211815571.USD","IE00BJLML261.HKD","LU0432979614.USD","SGXZ31699556.SGD","IE0004445015.USD","IE00BJJMRX11.SGD","LU0943347566.SGD","LU1814569148.SGD","LU2023250504.SGD","SG9999001176.USD","IE00B1XK9C88.USD","LU2023251221.USD","LU0320765059.SGD","LU2264538146.SGD","LU0787776722.HKD","SG9999014880.SGD","LU2237443382.USD","LLII","LU2602419157.SGD","LU2237443549.SGD","IE00BKDWB100.SGD","IE0002141913.USD","LU2168563687.JPY","LU1551013342.USD","JDOC","LU2089984988.USD","LU2236285917.USD","SGXZ51526630.SGD","LU1989771016.USD","LU2552382132.HKD","MHIP","LU1623119135.USD","LU0316494557.USD","FTXH","LU0323591593.USD","LU1868836591.USD","SGXZ99366536.SGD","BK4534","LU2265009873.SGD","BK4599","XBI","LU0256863902.USD","LU2491050071.SGD","LU1868837300.USD","LU2237443465.HKD","BK4588","LU2461242641.AUD","LU0823434740.USD","LLYZ","SG9999018865.SGD","LU1069344957.HKD","LU1720051017.SGD","LU1232071149.USD","TRUH","CURE","IYH","LU1366192091.USD","SG9999017495.SGD","LU0174119429.USD","BK4585","MEDX","LU1983299246.USD","SG9999013999.USD","LU2089284900.SGD","LU0096364046.USD","ELIS","LU2108987350.USD","IE00BFSS7M15.SGD","LU2237438978.USD","LU2271345857.HKD","LU0234572021.USD","LU2357305700.SGD","OZEM","LU2361044865.SGD","LU0672654240.SGD","LU0823434583.USD","LU0058720904.USD","LU2168564065.EUR","LU1093756168.USD","IE00B4R5TH58.HKD","LU1551013425.SGD","IE00BJJMRY28.SGD","LU1917777945.USD","LU2456880835.USD","LU1093756325.SGD","LU2746668461.USD","LU2750360641.GBP","LU2237443978.SGD","PPH","SG9999015986.USD","BK4581","BK4516","IE00B1BXHZ80.USD","IE00BJT1NW94.SGD","BK4533","LU0385154629.USD","LU0114720955.EUR","LU1974910355.USD","LU1629891620.HKD","IE00BFTCPJ56.SGD","LU1720051108.HKD","LU0203201768.USD","LU0353189680.USD","LU1691799644.USD","LU2106854487.HKD","IE0009355771.USD","LU0158827781.USD","LU1064131342.USD","LU2168564495.EUR","LU1868836757.USD","LU0109391861.USD","LU0238689110.USD","LU0882574055.USD","FHTX","VHT","IE00BFSS8Q28.SGD","SG9999014898.SGD","IHE","IE00BN29S564.USD","LU0823416689.USD","LU2491049909.HKD","LU0456855351.SGD","LU2063271972.USD","LU0354030438.USD","LU2750360997.AUD","IE00BK4W5M84.HKD","LU2471134523.USD","LU1057294990.SGD","ELIL","LU2756315664.SGD","LU1979441026.SGD","FHLC","SG9999015978.USD","LU2361045086.USD","LU0820562030.AUD","LU0640476718.USD","LU2023250330.USD","LU2896262040.SGD","LU1267930730.SGD","LU2361044949.HKD","LU2324357040.USD","SG9999014906.USD","LU1291159041.SGD","LU0689472784.USD","LU0158827948.USD","LU2087625088.SGD","LU0198837287.USD","LU0256863811.USD","LU2471134879.HKD","MEDI","LU1127390331.HKD","LU2168564149.EUR","LU0079474960.USD","LU0708995401.HKD","LU1868836914.USD","LU0882574139.USD","LU1023059063.AUD","SG9999001176.SGD","LU2112291526.USD","LU0097036916.USD","LU0006306889.USD","SG9999014914.USD","LU2471134796.USD","LU0683600562.USD","LU0094547139.USD","SG9999018857.SGD","LU0820561909.HKD","WDNA","LU0061475181.USD","LU2360106947.USD","IE00B7KXQ091.USD","LU0345770308.USD","SGXZ57979304.SGD","XLV","LU1280957306.USD","GDOC","LU0225283273.USD","LU0471298777.SGD","LU2491050154.USD","LU0266013472.USD","LU0786609619.USD","IE00B2B36J28.USD","LU2111349929.HKD","GB00BDT5M118.USD","LU2471134952.CNY","LU2746668974.SGD","LU1145028129.USD","LU2237443622.USD","IXJ","LU1988902786.USD","LU1868837136.USD","LU0889565916.HKD","LU2552382058.USD","LU2756315318.SGD","TMED","LU0106261372.USD","LU1712237335.SGD","SG9999015945.SGD","CANC","LU1548497426.USD","LU1323610961.USD","IE00BKPKM429.USD","SG9999015952.SGD","IE0001KFT4U8.USD","LU0320765992.SGD","LU0109394709.USD","IBB","LU2028103732.USD","LU2168564222.USD","RXL","BK4139","LU0353189763.USD","LU2468319806.SGD","LU2237443895.HKD","LU2213496289.HKD","LU0345770993.USD","BK4007","IE0004445239.USD","ILDR","LLYX","LU0122379950.USD","LU0417517546.SGD","LU1035775433.USD","THNR","SGXZ81514606.USD","LU0354030511.USD","IE00BK4W5L77.USD","LLY","LU0289739699.SGD","IE00B4JS1V06.HKD","LU0820561818.USD","LU2552382215.SGD","LU0133085943.USD","PJP","IE0005OL40V9.USD","LABU","LU1061106388.HKD","AGNG","HRTS","LU0466842654.USD","LU0203202063.USD","LU1804176565.USD","LU2417539215.USD","IE00BWXC8680.SGD","LU0471298694.HKD","LU0964807845.USD","IE00B775H168.HKD","LU2089283258.USD","LU2462157665.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672480761","title":"AbbVie (ABBV) Stock May Be 41% Undervalued On FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2672480761","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672480761?lang=en_us&edition=fundamental","pubTime":"2026-10-02 02:21","pubTimestamp":1790878886,"startTime":"0","endTime":"0","summary":"AbbVie’s AbbVie stock has had a strong multiyear run, and with the price recently closing at US$261.59, the key issue is whether that level is backed by the cash the business is expected to generate. Recent drug approvals, partnerships and data readouts all feed into those future cash flows, which is where the valuation debate now sits.\n\nOver the past 5 years AbbVie has delivered a total return of 187.5%, which puts real weight on the question of whether the current share price is fully...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/141885706-card/1789002767761","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/141885706-card/1789002767761"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-abbv/abbvie/news/abbvie-abbv-stock-may-be-41-undervalued-on-fda-approval","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-abbv/abbvie/news/abbvie-abbv-stock-may-be-41-undervalued-on-fda-approval","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PJP","LU2125909593.SGD","LU2433249047.HKD","LU2125909247.SGD","LU0256863902.USD","IYH","LU1037948541.HKD","DCF","LU0859254822.USD","LU0114720955.EUR","LU2468319806.SGD","ABBV","LU2089984988.USD","LU1670628061.USD","BK4139","FTXH","LU1430594728.SGD","LU1244550221.USD","LU1670627923.USD","LU0868494617.USD","MEDX","TRUH","PPH","BK4581","LABU","AGNG","LU0965508806.USD","LU0472753341.HKD","XLV","LU0726765562.USD","FHLC","LU0795875169.SGD","LU1093756168.USD","LU1929549753.HKD","BK4533","IXJ","VHT","LU2089284900.SGD","LU1720051017.SGD","JDOC","SPHQ","LU2129689514.USD","GLAM","BK4588","IE00B4R5TH58.HKD","RXL","LU1989772840.SGD","LU0689626769.HKD","LU2347655073.USD","SG9999011175.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672769149","title":"Trump Medicare Drug Pricing Model May Apply to Only Four Companies After Exemptions","url":"https://stock-news.laohu8.com/highlight/detail?id=2672769149","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672769149?lang=en_us&edition=fundamental","pubTime":"2026-10-02 01:54","pubTimestamp":1790877298,"startTime":"0","endTime":"0","summary":"Trump Medicare drug pricing model may apply to only four companies after exemptionsNEW YORK, Oct 1 (Reuters)-A Trump administration rule to cut hospital drug prices for Medicare patients may apply to ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nL1N45N0WX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0266013472.USD","IE00BK4W5L77.USD","LU0106261372.USD","LU0354030438.USD","LU1623119135.USD","LU2089984988.USD","LU2213496289.HKD","ILDR","IHE","LU2237443978.SGD","BK4534","IE00BJT1NW94.SGD","MHIP","PPH","IE00BK4W5M84.HKD","LU1551013425.SGD","IE00BFTCPJ56.SGD","LU2456880835.USD","LU2462157665.USD","LU0683600562.USD","IE0002270589.USD","LU2462591350.SGD","LU1691799644.USD","LU1720051108.HKD","ELIS","LU0234572021.USD","IE000M9KFDE8.USD","LU1868836591.USD","LU0889565916.HKD","IE00B19Z3B42.SGD","LU2756315318.SGD","LU0174119429.USD","LU0320765992.SGD","LU2106854487.HKD","SG9999011175.SGD","SGXZ51526630.SGD","LU2361044949.HKD","LU0061475181.USD","CURE","IE00B3T34201.USD","IE00BKPKM429.USD","LLII","LU1814569148.SGD","SG9999015986.USD","IYH","LU0385154629.USD","LU0640476718.USD","LU2112291526.USD","SG9999014880.SGD","LU2089284900.SGD","IE00B7KXQ091.USD","SG9999018865.SGD","LU0122379950.USD","BK4533","LU0114720955.EUR","LU2211815571.USD","LU2089283258.USD","LLY","LU1804176565.USD","LU2491050071.SGD","OZEM","LU0321505439.SGD","IE00B1BXHZ80.USD","LU2491049909.HKD","LU0353189763.USD","LU0306807586.USD","BK4588","LU0882574055.USD","LU1720051017.SGD","PFE","IE00BJJMRY28.SGD","LU0109391861.USD","IXJ","WDNA","LU0820561818.USD","BK4550","BK4599","LU2471134952.CNY","LU1064131342.USD","LU1983299246.USD","LU2491050154.USD","SG9999003800.SGD","LU2756315664.SGD","LU0256863902.USD","LU0672654240.SGD","LU0210536198.USD","LU1267930730.SGD","LU2471134796.USD","LU2552382058.USD","LU1868836757.USD","LU1066051498.USD","IE00BJJMRX11.SGD","SGXZ31699556.SGD","LU1366192091.USD","LU0787776722.HKD","LU2168564065.EUR","LU1894683264.USD","LU2596442595.SGD","SG9999002224.SGD","LU1712237335.SGD","LU0323591593.USD","LU2602419157.SGD","LU0096364046.USD","LLYX","LU0289739699.SGD","LU0097036916.USD","LU0345770993.USD","LU0345770308.USD","LU0353189680.USD","LU0256863811.USD","LLYZ","LU1023059063.AUD","LU1093756325.SGD","SG9999002232.USD","BK4516","BK4585","LU0058720904.USD","LU0198837287.USD","LU0432979614.USD","LU2237443382.USD","SG9999001176.USD","LU2237443465.HKD","LU0689472784.USD","IE00BBT3K403.USD","LU2471134523.USD","IE0004445015.USD","LU0823434740.USD","LU0823434583.USD","LU0985481810.HKD","LU2111349929.HKD","LU0238689110.USD","LU2168564149.EUR","SGXZ99366536.SGD","LU0320765059.SGD","LU0964807845.USD","LU1883839398.USD","LU2237438978.USD","LU0225771236.USD","LU2746668461.USD","LU2552382215.SGD","CANC","LU0109394709.USD","IE00B2B36J28.USD","LU0306806265.USD","LU1323610961.USD","LU2361045086.USD","SGXZ81514606.USD","TMED","LU1894683348.USD","LU2023251221.USD","LU0820561909.HKD","SG9999014898.SGD","LU0417517546.SGD","VHT","LU0868494617.USD","LU2028103732.USD","AGNG","LU1061106388.HKD","SG9999001176.SGD","FHLC","TRUH","IE00BLSP4239.USD","LU0158827948.USD","ELIL","LU0158827781.USD","LU2237443622.USD","LU1629891620.HKD","LU2108987350.USD","LU0943347566.SGD","LU2468319806.SGD","IE00BN29S564.USD","BK4592","LU2271345857.HKD","LU2063271972.USD","LU2361044865.SGD","HRTS","SG9999015952.SGD","LU1066053197.SGD","SG9999017495.SGD","IE00B1XK9C88.USD","SG9999014906.USD","SGXZ57979304.SGD","IE00B19Z3581.USD","BK4568","LU2461242641.AUD","LU0316494557.USD","LU2023250504.SGD","LU2552382132.HKD","IE00B4JS1V06.HKD","IE0002141913.USD","PJP","LU0471298694.HKD","LU1127390331.HKD","IE0009355771.USD","LU1280957306.USD","LU1035775433.USD","SG9999015978.USD","LU2023250330.USD","IE0005OL40V9.USD","GB00BDT5M118.USD","LU0456855351.SGD","LU0823416689.USD","LU1057294990.SGD","SG9999018857.SGD","LU1868836914.USD","LU1979441026.SGD","LU2746668974.SGD","LU1988902786.USD","LU1989771016.USD","IE00B775H168.HKD","GDOC","LU0471298777.SGD","LU1145028129.USD","LU1868837136.USD","LU0321505868.SGD","LU1093756168.USD","SG9999014914.USD","XLV","LU2750360997.AUD","LU2168563687.JPY","LU1548497426.USD","LU0786609619.USD","IE0004445239.USD","LU1917777945.USD","LU0203202063.USD","LU0354030511.USD","LU0170899867.USD","LU1069344957.HKD","LU1291159041.SGD","LU0094547139.USD","LU2237443549.SGD","LU0882574139.USD","SG9999015945.SGD","LU2417539215.USD","LU2750360641.GBP","MEDX","BK4581","LU0466842654.USD","IE00BJJMRZ35.SGD","IE00BJLML261.HKD","LU0133085943.USD","LU2087625088.SGD","JDOC","LU2168564495.EUR","LU2265009873.SGD","SG9999013999.USD","IE00BFSS7M15.SGD","BK4007","LU2324357040.USD","RXL","IE00BLSP4452.SGD","LU0079474960.USD","LU2360106947.USD","IE00BFSS8Q28.SGD","LU2896262040.SGD","IE00BKDWB100.SGD","LU0203201768.USD","LU0006306889.USD","LU2236285917.USD","LU0225284248.USD","LU0820562030.AUD","LU2471134879.HKD","IE00BWXC8680.SGD","LU1974910355.USD","LU0225283273.USD","THNR","LU1232071149.USD","LU2357305700.SGD","LU2237443895.HKD","IE00B4R5TH58.HKD","LU1551013342.USD","LU0708995401.HKD","LU2264538146.SGD","FTXH","LU2168564222.USD","MEDI","IE0001KFT4U8.USD","LU1868837300.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672766900","title":"Merck's Tulisokibart Data From Hidradenitis Suppurativa Trial Looks Solid, UBS Securities Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2672766900","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672766900?lang=en_us&edition=fundamental","pubTime":"2026-10-02 00:38","pubTimestamp":1790872694,"startTime":"0","endTime":"0","summary":"Merck's  data from a phase 2b study evaluating tulisokibart in hidradenitis suppurativa looks solid, potentially adding another indication for tulisokibart as management plans to advance into a phase 3 trial, UBS Securities said in a note Wednesday.The company reported a 29% to 37% placebo adjusted hidradenitis suppurativa clinical response 50 between the four-week dose and two-week dose at week 16, which appeared to be in-line or better than the phase 2 data from UCB's Bimzelx, the investment firm said.Even if phase 3 efficacy comes down slightly, UBS said tulisokibart could still be a meaningfully differentiated product as a novel mechanism compared with current standard of care.As tulisokibart can be dosed either at a two-week interval or a four-week interval, the investigational drug could be priced slightly higher with potentially more frequent dosing for the hidradenitis suppurativa indication, the firm said.UBS Securities has a buy rating on the stock, with a $175 price target.M","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SGXZ57979304.SGD","BK4550","LU1989772923.USD","SG9999001176.SGD","LU1291159041.SGD","RXL","LU0162691827.USD","LU1162221912.USD","LU1941712264.USD","LU1066051811.HKD","LU2324357040.USD","LU2357627491.SGD","LU1093756325.SGD","LU0265550359.USD","LU2361044865.SGD","BK4588","XLV","LU0985320562.USD","BK4516","PPH","LU2360032135.SGD","IE0002141913.USD","SG9999014567.USD","FTXH","LU2491049909.HKD","LU0965509101.SGD","LU1069347547.HKD","VHT","IE0009355771.USD","LU2023250504.SGD","BK4585","LU0289739343.SGD","LU0823416689.USD","SG9999013999.USD","GDOC","LU0058720904.USD","IE00BLSP4452.SGD","LU0124676726.USD","LU0069063385.USD","BK4534","LU0072461881.USD","LU1057294990.SGD","LU1585245621.USD","LU1061106388.HKD","SG9999014542.SGD","SG9999014575.USD","BK4559","LU2491050154.USD","LU2361045086.USD","LU0234572021.USD","LU1116320901.HKD","LU0861579265.USD","LU0106261372.USD","LU0070302665.USD","LU0203347892.USD","IE00BSNM7G36.USD","LU0208291251.USD","LU2433249047.HKD","SG9999014559.SGD","LU1032466523.USD","IE00BFTCPJ56.SGD","LU0266013472.USD","LU2125909247.SGD","BK4533","LU1035773651.USD","LU1093756168.USD","HRTS","LU0320765646.SGD","LU0689626769.HKD","LU0238689110.USD","LU1934455194.USD","LU1201861249.SGD","LU1430594728.SGD","SG9999001440.SGD","LU2468319806.SGD","LU0320765489.SGD","MRK","IE000M9KFDE8.USD","LU0289739699.SGD","LU0211331839.USD","LU1923622614.USD","LU1974910355.USD","LU0859254822.USD","LU0965508806.USD","LU1917777945.USD","LU0265550946.USD","IXJ","LU1934455277.USD","SG9999001176.USD","LU2125909593.SGD","LU2125154935.USD","LU0511384066.AUD","LU1571399168.USD","IE00BJT1NW94.SGD","TRUH","LU0648001328.SGD","SG9999015341.SGD","LU0432979614.USD","LU0942090050.USD","IE00B2B36J28.USD","LU0130102774.USD","LU2125154778.USD","LU2023250843.SGD","IE00B1BXHZ80.USD","LU0980610538.SGD","LU2112291526.USD","LU0098860793.USD","LU1037948897.HKD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU1941712348.USD","PAWZ","LU0122379950.USD","IE00BBT3K403.USD","LU0057025933.USD","SG9999002232.USD","JDOC","LU2106854487.HKD","LU2089984988.USD","LU1934455863.HKD","LU1989771016.USD","LU2461242641.AUD","SG9999015358.SGD","BMED","LU0006306889.USD","LU0868494708.USD","SG9999002224.SGD","IYH","LU1066053197.SGD","LU1989772840.SGD","LU1037948541.HKD","LU0965509283.SGD","IE00BLSP4239.USD","LU0868494617.USD","IHE","LU1929549753.HKD","BK4007","IE00BN8TJ469.HKD","LU0472753341.HKD","LU1066051225.USD","LU2491050071.SGD","LU0130517989.USD","FHLC","LU1023059063.AUD","LU0965509010.AUD","LU1983299246.USD","LU0203345920.USD","LU1699723380.USD","LU0477156953.USD","LU2361044949.HKD","LU1066051498.USD","LU1116320737.USD","LU0289961442.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672699766","title":"Eli Lilly's Obesity Data Support Broader Portfolio Beyond Tirzepatide, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2672699766","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672699766?lang=en_us&edition=fundamental","pubTime":"2026-10-02 00:29","pubTimestamp":1790872162,"startTime":"0","endTime":"0","summary":"Eli Lilly's  new obesity data support a broader drug portfolio beyond tirzepatide, or TZP, UBS Securities said.The analysts said in a note Wednesday that the company presented new data at the European Association for the Study of Diabetes showing that its second- and third-generation obesity drugs can deliver more than 20% weight loss in both obesity and obesity patients with type 2 diabetes, with results that appear better than tirzepatide.UBS highlighted data for eloralintide plus tirzepatide, which showed strong weight-loss results broadly in line with retatrutide. Eloralintide could help patients who cannot tolerate GLP-1 drugs or do not lose enough weight, while retatrutide could offer another option for patients with higher liver fat, UBS said.The investment firm said Lilly is building a strong incretin portfolio beyond tirzepatide, with newer drugs offering additional treatment options and potentially superior efficacy.UBS has a buy rating and a $1,425 price target on Eli Lilly.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B4JS1V06.HKD","LU2462591350.SGD","LU1548497426.USD","VHT","LU1035775433.USD","OZEM","SG9999018857.SGD","LU1629891620.HKD","BK4007","LU1057294990.SGD","ILDR","LU0096364046.USD","LU2461242641.AUD","LU0203201768.USD","LU1868836591.USD","LU1323610961.USD","IE00BN29S564.USD","MEDX","LU0417517546.SGD","LU1127390331.HKD","LU1917777945.USD","LU1974910355.USD","LU2237443465.HKD","LU1291159041.SGD","LU1023059063.AUD","LU1989771016.USD","LU0133085943.USD","LU0158827948.USD","LU2112291526.USD","LU2746668461.USD","IE0004445015.USD","LU0823434583.USD","LU1093756168.USD","LU2063271972.USD","LU0786609619.USD","LU2357305700.SGD","IE00BFSS7M15.SGD","PJP","LU0672654240.SGD","LU1804176565.USD","IE00B1XK9C88.USD","LU2746668974.SGD","LU0079474960.USD","LU0354030511.USD","IE0001KFT4U8.USD","LU2552382132.HKD","LU1280957306.USD","BK4533","JDOC","AGNG","LU1232071149.USD","IE00BFTCPJ56.SGD","LU0471298694.HKD","LU0823416689.USD","CURE","LLYX","LU0289739699.SGD","LU1988902786.USD","LU2750360641.GBP","WDNA","LU0238689110.USD","LU2265009873.SGD","LU0158827781.USD","LU1814569148.SGD","LU2108987350.USD","LU2023250504.SGD","LU2089283258.USD","LU2750360997.AUD","IE0002141913.USD","LU0109391861.USD","IE00B2B36J28.USD","GDOC","LU1093756325.SGD","IE00BK4W5M84.HKD","LU0122379950.USD","LU1267930730.SGD","LLII","BK4534","LU0061475181.USD","SG9999001176.SGD","BK4588","LU0266013472.USD","LU2237443382.USD","LU2168564495.EUR","LU0106261372.USD","LU2168563687.JPY","IE00BKPKM429.USD","LU2168564222.USD","SG9999017495.SGD","LU2491049909.HKD","IE0005OL40V9.USD","SG9999013999.USD","LU1064131342.USD","LLYZ","IE00BJJMRZ35.SGD","LU1366192091.USD","LU0316494557.USD","LU1691799644.USD","LU2111349929.HKD","LU2361045086.USD","IE00BJJMRX11.SGD","ELIS","TRUH","IE00B1BXHZ80.USD","LU1720051108.HKD","HRTS","LU2211815571.USD","LU0683600562.USD","LU0787776722.HKD","MEDI","LU2602419157.SGD","LU0354030438.USD","LU0708995401.HKD","LU2237443549.SGD","SG9999001176.USD","IE00BWXC8680.SGD","LU0820561909.HKD","BK4599","LU0210536198.USD","LU1551013342.USD","LU2106854487.HKD","LU1712237335.SGD","LU1868837136.USD","LU2271345857.HKD","LU2089984988.USD","LU2552382215.SGD","SG9999014898.SGD","LU2471134796.USD","IE00BJJMRY28.SGD","IE00BKDWB100.SGD","LU0471298777.SGD","LU1061106388.HKD","LU2324357040.USD","LU2237443978.SGD","LU2360106947.USD","FTXH","LU2213496289.HKD","LU0094547139.USD","LU2471134879.HKD","LU2361044949.HKD","SGXZ51526630.SGD","SGXZ99366536.SGD","LU2417539215.USD","LU0889565916.HKD","LU0820562030.AUD","LU0820561818.USD","CANC","GB00BDT5M118.USD","IE00B7KXQ091.USD","LU0256863811.USD","SG9999014914.USD","LU2023250330.USD","BK4581","BK4516","LU0345770308.USD","LU0345770993.USD","FHLC","LU0385154629.USD","LU0964807845.USD","LU1623119135.USD","LU0198837287.USD","LU0174119429.USD","LU0058720904.USD","IHE","IXJ","LU0466842654.USD","SGXZ31699556.SGD","XLV","LU1983299246.USD","THNR","LU2087625088.SGD","LU0320765059.SGD","LU1868836757.USD","LU2028103732.USD","LU2471134952.CNY","LU1145028129.USD","SG9999014906.USD","SG9999014880.SGD","IE00BK4W5L77.USD","LU0456855351.SGD","LU1868837300.USD","LU0882574055.USD","LLY","LU0823434740.USD","LU0323591593.USD","LU2361044865.SGD","LU2236285917.USD","LU2023251221.USD","SG9999015986.USD","RXL","LU2471134523.USD","SG9999018865.SGD","SGXZ57979304.SGD","MHIP","LU0203202063.USD","IE00BFSS8Q28.SGD","LU1069344957.HKD","LU2462157665.USD","IE00B4R5TH58.HKD","PPH","LU2468319806.SGD","IE0009355771.USD","LU2756315318.SGD","TMED","IE00BJT1NW94.SGD","LU0943347566.SGD","LU1720051017.SGD","LU0353189680.USD","LU2896262040.SGD","LU2756315664.SGD","LU0097036916.USD","LU1868836914.USD","LU0114720955.EUR","LU2264538146.SGD","SG9999015952.SGD","LU2491050071.SGD","ELIL","LU0353189763.USD","LU2168564065.EUR","IE00B775H168.HKD","LU0006306889.USD","LU2456880835.USD","LU2237438978.USD","SGXZ81514606.USD","LU0320765992.SGD","LU1551013425.SGD","LU2552382058.USD","LU2089284900.SGD","LU1979441026.SGD","SG9999015945.SGD","LU0109394709.USD","LU2491050154.USD","LU0256863902.USD","IE00BJLML261.HKD","IYH","SG9999015978.USD","IE0004445239.USD","LU2237443622.USD","LU2237443895.HKD","LU0225283273.USD","LU0432979614.USD","LU0234572021.USD","LU0882574139.USD","LU2168564149.EUR","BK4585","LU0640476718.USD","LU0689472784.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672676557","title":"Eli Lilly (LLY) Ends Cancer Development Deal with Foghorn Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2672676557","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672676557?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:31","pubTimestamp":1790868692,"startTime":"0","endTime":"0","summary":"Pharmaceutical giant Eli Lilly ($LLY) has ended a deal it had in place to develop cancer treatments with Foghorn Therapeutics ($FHTX). News of the ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/eli-lilly-lly-ends-cancer-development-deal-with-foghorn-therapeutics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/eli-lilly-lly-ends-cancer-development-deal-with-foghorn-therapeutics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BN29S564.USD","LU0174119429.USD","LU1291159041.SGD","LU2896262040.SGD","IXJ","LU2023250504.SGD","LU2023251221.USD","BK4588","IE00BFSS7M15.SGD","LU2111349929.HKD","SG9999015986.USD","LU2237443549.SGD","LU1988902786.USD","LU1548497426.USD","SGXZ81514606.USD","ELIL","LU1551013425.SGD","LU2461242641.AUD","LU1868836914.USD","LU2552382132.HKD","LU0787776722.HKD","BK4516","LU0096364046.USD","LU1868837136.USD","GDOC","LU2063271972.USD","IE0004445015.USD","SG9999013999.USD","LU0471298777.SGD","LU2271345857.HKD","LU2211815571.USD","LU0109391861.USD","LU0471298694.HKD","LU0820562030.AUD","LU2264538146.SGD","LU2265009873.SGD","LU0061475181.USD","LU1868836591.USD","LU2462157665.USD","IE00BK4W5L77.USD","LU2756315318.SGD","IE0009355771.USD","LLII","LU0238689110.USD","LU1093756168.USD","SGXZ99366536.SGD","LU2471134796.USD","LU1323610961.USD","LU1061106388.HKD","LU0320765992.SGD","LU2237443382.USD","SG9999018865.SGD","LU1366192091.USD","IE00BKPKM429.USD","LU2089283258.USD","LU0354030438.USD","LU2324357040.USD","SG9999018857.SGD","LU2361044865.SGD","GB00BDT5M118.USD","LU0225283273.USD","LU0210536198.USD","LU0203202063.USD","LU1035775433.USD","SGXZ31699556.SGD","LU1145028129.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU1720051017.SGD","LU0106261372.USD","BK4139","LU0708995401.HKD","IE00B775H168.HKD","LU2236285917.USD","WDNA","LU0882574055.USD","LU1064131342.USD","IE00BJLML261.HKD","LU2112291526.USD","LU2491050071.SGD","SG9999001176.SGD","SG9999014898.SGD","LU0345770993.USD","ELIS","HRTS","LLY","FHTX","LU0882574139.USD","MEDX","IE0001KFT4U8.USD","LU0114720955.EUR","LU1974910355.USD","LU2602419157.SGD","SG9999001176.USD","BK4533","CANC","LU2471134523.USD","SGXZ51526630.SGD","IE00BJJMRY28.SGD","LU1267930730.SGD","LU0385154629.USD","LU2237443895.HKD","BK4581","LU0823434583.USD","FTXH","LU0158827948.USD","IE00BK4W5M84.HKD","IE00B7KXQ091.USD","LU1712237335.SGD","SGXZ57979304.SGD","RXL","LLYZ","SG9999015978.USD","LU2028103732.USD","LU0006306889.USD","LU0345770308.USD","IE00B2B36J28.USD","JDOC","LU2023250330.USD","LU2168563687.JPY","LU2417539215.USD","LU2746668461.USD","PPH","LU1989771016.USD","MHIP","LU2468319806.SGD","LU0456855351.SGD","LU2213496289.HKD","LU2361045086.USD","LU0234572021.USD","BK4585","LLYX","ILDR","LU0466842654.USD","LU0079474960.USD","LU1623119135.USD","LU2456880835.USD","AGNG","LU1232071149.USD","LU2087625088.SGD","LU0316494557.USD","LU0353189680.USD","LU0786609619.USD","PJP","SG9999014914.USD","LU2168564222.USD","TRUH","LU0683600562.USD","CURE","LU0823416689.USD","FHLC","LU0266013472.USD","LU0640476718.USD","LU0964807845.USD","IE00BKDWB100.SGD","LU1720051108.HKD","IHE","IE0005OL40V9.USD","LU2089284900.SGD","LU1057294990.SGD","LU2360106947.USD","SG9999017495.SGD","IE00BWXC8680.SGD","LU0133085943.USD","SG9999014906.USD","BK4007","LU0320765059.SGD","LU0823434740.USD","LU2746668974.SGD","LU0943347566.SGD","LU1093756325.SGD","LU2491049909.HKD","LU2361044949.HKD","LU2108987350.USD","LU0323591593.USD","LU0097036916.USD","LU0198837287.USD","LU0672654240.SGD","IE00BFSS8Q28.SGD","BK4599","LU1069344957.HKD","LU1804176565.USD","LU1868836757.USD","LU2168564495.EUR","LU1551013342.USD","LU2756315664.SGD","LU2168564065.EUR","TMED","LU0203201768.USD","LU0820561818.USD","LU0889565916.HKD","LU0289739699.SGD","IE0004445239.USD","LU1868837300.USD","LU0820561909.HKD","LU2471134952.CNY","LU1691799644.USD","LU0109394709.USD","LU1127390331.HKD","IE00B1BXHZ80.USD","LU0094547139.USD","LU1023059063.AUD","IE00B1XK9C88.USD","SG9999015952.SGD","IE00B4JS1V06.HKD","LU0122379950.USD","LU1983299246.USD","MEDI","LU2750360997.AUD","LU2552382215.SGD","LU1629891620.HKD","LU2106854487.HKD","SG9999014880.SGD","XLV","LU2471134879.HKD","LU2552382058.USD","LU0256863811.USD","IYH","LU2237443978.SGD","LU1917777945.USD","LU2750360641.GBP","LU0353189763.USD","LU2237443465.HKD","LU2237438978.USD","LU0417517546.SGD","LU2237443622.USD","LU1979441026.SGD","LU2491050154.USD","IE0002141913.USD","IE00BJJMRX11.SGD","LU0058720904.USD","LU0432979614.USD","LU2357305700.SGD","LU2462591350.SGD","LU1814569148.SGD","IE00BJT1NW94.SGD","BK4534","OZEM","LU0256863902.USD","LU2089984988.USD","THNR","SG9999015945.SGD","VHT","IE00BJJMRZ35.SGD","LU0158827781.USD","LU1280957306.USD","LU0689472784.USD","LU2168564149.EUR","LU0354030511.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672768348","title":"AbbVie Says Phase 3 Trials Show Rinvoq Vitiligo Repigmentation Gains Extend to Week 76","url":"https://stock-news.laohu8.com/highlight/detail?id=2672768348","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672768348?lang=en_us&edition=fundamental","pubTime":"2026-10-01 22:02","pubTimestamp":1790863328,"startTime":"0","endTime":"0","summary":"AbbVie says Phase 3 trials show Rinvoq vitiligo repigmentation gains extend to week 76AbbVie disclosed long-term Phase 3 Viti-Up results for RINVOQ in non-segmental vitiligo, presented at the 2026 EAD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL8fkyL2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","ABBV","LU2237443382.USD","LU1585245621.USD","LU1720051017.SGD","LU0965508806.USD","FTXH","AGNG","PPH","IXJ","JDOC","LU1983299246.USD","GLAM","LU1496350502.SGD","LU0949170772.SGD","TRUH","LU0511384066.AUD","LU1093756325.SGD","VHT","IYH","LU2357627491.SGD","LU2237443895.HKD","BK4559","LU0098860793.USD","LU0708994859.HKD","LU0289739343.SGD","LU0128525929.USD","LU0320765646.SGD","FHLC","LU0965509101.SGD","IE00BJJMRZ35.SGD","BK4588","PJP","IE000SO60NU8.SGD","LU0661504455.SGD","LU2347655156.SGD","LU1291159041.SGD","IE000BZT7R73.USD","LU0198837287.USD","RXL","LU0553294199.USD","LU1989771016.USD","IE00BFTCPJ56.SGD","XLV","IE00B4R5TH58.HKD","LU0256863902.USD","LU1023059063.AUD","IE00BLSP4239.USD","IE00BVYPNV92.GBP","LU0417517546.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672768892","title":"Abbvie - Phase 3 Studies Show Continued Repigmentation with Rinvoq Through Week 76","url":"https://stock-news.laohu8.com/highlight/detail?id=2672768892","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672768892?lang=en_us&edition=fundamental","pubTime":"2026-10-01 22:00","pubTimestamp":1790863226,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45N1K6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2347655073.USD","IE00B2B36J28.USD","IYH","LU0868494708.USD","XLV","LU1934455194.USD","BK4139","LU0256863811.USD","LU2089283258.USD","SG9999003800.SGD","LU0170899867.USD","ABBV","LU0943347566.SGD","IE00BN8TJ469.HKD","RXL","TRUH","LU0965508806.USD","LU2129689431.USD","LU0859254822.USD","IE00BDGV0183.EUR","LU0114720955.EUR","FTXH","IXJ","IE00BGHQF631.EUR","LU0069063385.USD","LU0795875169.SGD","LU1670628061.USD","LU0795875086.SGD","LU2237443549.SGD","IE00BSNM7G36.USD","PJP","LU2433249047.HKD","MEDX","GLAM","LU2129689514.USD","AGNG","VHT","LU1430594728.SGD","JDOC","LU2237443382.USD","PPH","LU1839511570.USD","IE00B4R5TH58.HKD","SG9999015945.SGD","IE000MB6IJN5.SGD","LU1074936037.SGD","LU1244550221.USD","FHLC","LU1291159041.SGD","LU0417517546.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672688977","title":"Abbvie - Rinvoq Plus NB-Uvb Shows Higher Repigmentation than Rinvoq Alone","url":"https://stock-news.laohu8.com/highlight/detail?id=2672688977","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672688977?lang=en_us&edition=fundamental","pubTime":"2026-10-01 22:00","pubTimestamp":1790863226,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45N1K6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE000WAW04H5.SGD","LU1037948897.HKD","LU1291159041.SGD","LU0058720904.USD","SG9999015945.SGD","LU0158827948.USD","IE00B4R5TH58.HKD","LU0198837287.USD","LU1934455194.USD","LU1718418525.SGD","LU2087621335.USD","LU0203347892.USD","LU0661504455.SGD","ABBV","LU1037948541.HKD","PPH","RXL","SG9999015986.USD","LU0128525929.USD","IE0002141913.USD","JDOC","LU0868494617.USD","LU2125909593.SGD","LU0114720955.EUR","BK4550","IE0004445239.USD","XLV","FTXH","IE00BFTCPJ56.SGD","IE00BN8TJ469.HKD","LU1720051108.HKD","LU1989772840.SGD","LU0820561818.USD","PJP","LU0726765562.USD","GLAM","LU0234570918.USD","LU0310799852.SGD","IE000F7OJYX1.SGD","VHT","AGNG","TRUH","IYH","LU1057294990.SGD","MEDX","FHLC","LU2089283258.USD","IXJ","LU2357305700.SGD","LU1074936037.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672768856","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (OtherSNYNF), Sagimet Biosciences, Inc. Class A (SGMT) and Eli Lilly & Co (LLY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672768856","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672768856?lang=en_us&edition=fundamental","pubTime":"2026-10-01 21:50","pubTimestamp":1790862609,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sanofi (SNYNF), Sagimet Biosciences, Inc. Class A ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-sanofi-othersnynf-sagimet-biosciences-inc-class-a-sgmt-and-eli-lilly-co-lly-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-sanofi-othersnynf-sagimet-biosciences-inc-class-a-sgmt-and-eli-lilly-co-lly-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B4JS1V06.HKD","LU2462591350.SGD","LU1548497426.USD","VHT","LU1035775433.USD","OZEM","SG9999018857.SGD","LU1629891620.HKD","BK4007","LU1057294990.SGD","ILDR","LU0096364046.USD","LU2461242641.AUD","LU0203201768.USD","LU1868836591.USD","LU1323610961.USD","IE00BN29S564.USD","MEDX","LU0417517546.SGD","LU1127390331.HKD","LU1917777945.USD","SNYNF","LU1974910355.USD","LU2237443465.HKD","LU1291159041.SGD","LU1023059063.AUD","LU1989771016.USD","LU0133085943.USD","LU0158827948.USD","LU2112291526.USD","LU2746668461.USD","IE0004445015.USD","LU0823434583.USD","LU1093756168.USD","LU2063271972.USD","LU0786609619.USD","LU2357305700.SGD","IE00BFSS7M15.SGD","PJP","LU0672654240.SGD","LU1804176565.USD","IE00B1XK9C88.USD","LU2746668974.SGD","LU0079474960.USD","LU0354030511.USD","IE0001KFT4U8.USD","LU2552382132.HKD","LU1280957306.USD","BK4533","JDOC","AGNG","LU1232071149.USD","IE00BFTCPJ56.SGD","LU0471298694.HKD","LU0823416689.USD","CURE","LLYX","LU0289739699.SGD","LU1988902786.USD","LU2750360641.GBP","WDNA","LU0238689110.USD","LU2265009873.SGD","LU0158827781.USD","LU1814569148.SGD","LU2108987350.USD","LU2023250504.SGD","LU2089283258.USD","LU2750360997.AUD","IE0002141913.USD","LU0109391861.USD","IE00B2B36J28.USD","GDOC","LU1093756325.SGD","IE00BK4W5M84.HKD","LU0122379950.USD","LU1267930730.SGD","LLII","BK4534","LU0061475181.USD","SG9999001176.SGD","BK4588","LU0266013472.USD","LU2237443382.USD","LU2168564495.EUR","LU0106261372.USD","LU2168563687.JPY","IE00BKPKM429.USD","LU2168564222.USD","SG9999017495.SGD","LU2491049909.HKD","IE0005OL40V9.USD","SG9999013999.USD","LU1064131342.USD","SGMT","LLYZ","IE00BJJMRZ35.SGD","LU1366192091.USD","LU0316494557.USD","LU1691799644.USD","LU2111349929.HKD","LU2361045086.USD","IE00BJJMRX11.SGD","ELIS","TRUH","IE00B1BXHZ80.USD","LU1720051108.HKD","HRTS","LU2211815571.USD","LU0683600562.USD","LU0787776722.HKD","MEDI","LU2602419157.SGD","LU0354030438.USD","LU0708995401.HKD","LU2237443549.SGD","SG9999001176.USD","IE00BWXC8680.SGD","LU0820561909.HKD","BK4599","LU0210536198.USD","LU1551013342.USD","LU2106854487.HKD","LU1712237335.SGD","LU1868837136.USD","LU2271345857.HKD","LU2089984988.USD","LU2552382215.SGD","SG9999014898.SGD","LU2471134796.USD","IE00BJJMRY28.SGD","IE00BKDWB100.SGD","LU0471298777.SGD","LU1061106388.HKD","LU2324357040.USD","LU2237443978.SGD","LU2360106947.USD","FTXH","LU2213496289.HKD","LU0094547139.USD","LU2471134879.HKD","LU2361044949.HKD","SGXZ51526630.SGD","SGXZ99366536.SGD","LU2417539215.USD","LU0889565916.HKD","LU0820562030.AUD","LU0820561818.USD","CANC","GB00BDT5M118.USD","IE00B7KXQ091.USD","LU0256863811.USD","SG9999014914.USD","LU2023250330.USD","BK4581","BK4516","LU0345770308.USD","LU0345770993.USD","FHLC","LU0385154629.USD","LU0964807845.USD","LU1623119135.USD","LU0198837287.USD","LU0174119429.USD","LU0058720904.USD","IHE","IXJ","LU0466842654.USD","SGXZ31699556.SGD","LU1983299246.USD","THNR","LU2087625088.SGD","LU0320765059.SGD","LU1868836757.USD","LU2028103732.USD","LU2471134952.CNY","LU1145028129.USD","SG9999014906.USD","SG9999014880.SGD","IE00BK4W5L77.USD","LU0456855351.SGD","LU1868837300.USD","LU0882574055.USD","LLY","LU0823434740.USD","LU0323591593.USD","LU2361044865.SGD","LU2236285917.USD","LU2023251221.USD","SG9999015986.USD","RXL","LU2471134523.USD","SG9999018865.SGD","SGXZ57979304.SGD","MHIP","LU0203202063.USD","IE00BFSS8Q28.SGD","LU1069344957.HKD","LU2462157665.USD","IE00B4R5TH58.HKD","PPH","LU2468319806.SGD","IE0009355771.USD","LU2756315318.SGD","TMED","IE00BJT1NW94.SGD","LU0943347566.SGD","LU1720051017.SGD","LU0353189680.USD","LU2896262040.SGD","LU2756315664.SGD","LU0097036916.USD","LU1868836914.USD","LU0114720955.EUR","LU2264538146.SGD","SG9999015952.SGD","LU2491050071.SGD","ELIL","LU0353189763.USD","LU2168564065.EUR","IE00B775H168.HKD","LU0006306889.USD","LU2456880835.USD","LU2237438978.USD","SGXZ81514606.USD","LU0320765992.SGD","LU1551013425.SGD","LU2552382058.USD","LU2089284900.SGD","LU1979441026.SGD","BK4139","SG9999015945.SGD","LU0109394709.USD","LU2491050154.USD","LU0256863902.USD","IE00BJLML261.HKD","IYH","SG9999015978.USD","IE0004445239.USD","LU2237443622.USD","LU2237443895.HKD","LU0225283273.USD","LU0432979614.USD","LU0234572021.USD","LU0882574139.USD","LU2168564149.EUR","BK4585","LU0640476718.USD","LU0689472784.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672542797","title":"AbbVie to Host Third-Quarter 2026 Earnings Call Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2672542797","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672542797?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:02","pubTimestamp":1790856149,"startTime":"0","endTime":"0","summary":"AbbVie to host third-quarter 2026 earnings call webcastAbbVie will release third-quarter 2026 results on Oct. 30, 2026, before the market opens.An earnings conference call webcast is scheduled for Oct","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL9LQL2j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023059063.AUD","LU0456855351.SGD","LU0058720904.USD","LU0661504455.SGD","AGNG","IE00BDGV0183.EUR","LU1670627923.USD","IE0009355771.USD","LU1496350502.SGD","LU1548497426.USD","FHLC","LU0310799852.SGD","FTXH","XLV","LU0689626769.HKD","LU0965509283.SGD","TRUH","LU1162221912.USD","LU0158827948.USD","SG9999015986.USD","ABBV","LU2433249047.HKD","LU0942090050.USD","LU0965509101.SGD","IE00BSNM7G36.USD","IE0000B7K699.USD","PJP","JDOC","LU2237443622.USD","LU0289739699.SGD","LU0395794307.EUR","LU2125909247.SGD","MEDX","IE00B2B36J28.USD","LU2357305700.SGD","LU0114720955.EUR","LU2357627491.SGD","IE00B19Z3581.USD","RXL","IXJ","LU1839511570.USD","PPH","IYH","VHT","LU0069063385.USD","LU1934455194.USD","LU1720051108.HKD","GLAM","SG9999015978.USD","LU0124676726.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672375435","title":"Foghorn Therapeutics Slashes Jobs After Ending Cancer Drug Trials with Ely Lilly","url":"https://stock-news.laohu8.com/highlight/detail?id=2672375435","media":"Dow Jones","labels":["executive","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672375435?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:40","pubTimestamp":1790854800,"startTime":"0","endTime":"0","summary":"Foghorn Therapeutics and Eli Lilly will abandon joint development of their lead oncology candidate and cut roughly 40% of Foghorn's workforce following disappointing phase 1 trial results.Foghorn shares in Thursday's premarket trading were down 44% to $2.00.The biotechnology company on Thursday said they have decided to stop advancing FHD-909 into the clinical development expansion phase, and end their SMARCA2 partnership after data showed the drug failed to deliver sufficient efficacy in targeting lung cancer.\"Unfortunately, the biology of the SMARCA2/4 synthetic lethality relationship has not translated into the level of efficacy required to further advance the program,\" said Foghorn Chief Executive Adrian Gottschalk.Foghorn's board approved a strategic reprioritization on Sept. 30 that will eliminate about 40% of its staff-leaving the biotech with roughly 65 full-time employees.The moves are expected to extend the company's cash runway to fund its priority programs into the second h","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443622.USD","SG9999001176.USD","LU2089984988.USD","IE00B7KXQ091.USD","IE00BJJMRY28.SGD","LU0672654240.SGD","LU2491049909.HKD","LU2602419157.SGD","IHE","IE00B4R5TH58.HKD","LU2468319806.SGD","LU1035775433.USD","LU0320765059.SGD","LU0823434740.USD","BK4534","LU2237438978.USD","LU2111349929.HKD","LU1291159041.SGD","LU0058720904.USD","IXJ","WDNA","LU2023250504.SGD","LU2168564065.EUR","LU1868836914.USD","PPH","XLV","BK4581","CANC","LU2023250330.USD","MEDI","SG9999015986.USD","IE00BFSS8Q28.SGD","GB00BDT5M118.USD","LU1069344957.HKD","LU0456855351.SGD","LU1988902786.USD","LU0266013472.USD","LU0820561909.HKD","SG9999015978.USD","BK4599","LU1804176565.USD","ILDR","IE0004445015.USD","LU1983299246.USD","ELIS","LU0689472784.USD","LU2471134879.HKD","LU2063271972.USD","LU0323591593.USD","LU2462591350.SGD","LU0345770308.USD","LU2491050071.SGD","LU2750360641.GBP","SGXZ31699556.SGD","TMED","FTXH","LU1232071149.USD","IE00BJLML261.HKD","LU0256863811.USD","LU0683600562.USD","SG9999014898.SGD","SGXZ57979304.SGD","LU0114720955.EUR","LU1127390331.HKD","LU0354030438.USD","LU0133085943.USD","LU2361045086.USD","LU2756315664.SGD","SG9999015952.SGD","LU0882574055.USD","BK4139","LU0354030511.USD","LU0320765992.SGD","LU0096364046.USD","LU1691799644.USD","LU2237443382.USD","LU2462157665.USD","LU2106854487.HKD","LU0417517546.SGD","BK4588","LU0708995401.HKD","LU0823434583.USD","IE0002141913.USD","LU0943347566.SGD","LU1551013425.SGD","LU2108987350.USD","CURE","GDOC","LU2361044865.SGD","LU1061106388.HKD","LU1868837300.USD","LU2237443549.SGD","BK4516","IE00B4JS1V06.HKD","LU1720051017.SGD","LU0174119429.USD","PJP","LU2112291526.USD","IE0009355771.USD","BK4585","LU0640476718.USD","LU0820562030.AUD","LU2237443895.HKD","IE00BKPKM429.USD","IE00BN29S564.USD","LU2471134523.USD","LU2168563687.JPY","LU2023251221.USD","LU2491050154.USD","LU0109391861.USD","LU2271345857.HKD","LU2264538146.SGD","SG9999018857.SGD","LLYZ","IE00B1BXHZ80.USD","LU0094547139.USD","LU0964807845.USD","SG9999001176.SGD","IE0005OL40V9.USD","LU1093756325.SGD","BK4007","LU2168564495.EUR","IE00BJT1NW94.SGD","SGXZ51526630.SGD","LU1093756168.USD","LU2417539215.USD","LU1917777945.USD","LU2168564222.USD","LU0079474960.USD","LU0256863902.USD","LU2089284900.SGD","IE00B775H168.HKD","LU0225283273.USD","LU0122379950.USD","SG9999013999.USD","LU1974910355.USD","IE00BJJMRX11.SGD","IE00BK4W5L77.USD","AGNG","LU1551013342.USD","LU2471134796.USD","LU2357305700.SGD","LU2896262040.SGD","HRTS","LU2324357040.USD","LU2461242641.AUD","LU2265009873.SGD","IE0004445239.USD","LU1023059063.AUD","SG9999014906.USD","LU2746668461.USD","LU1145028129.USD","LU2237443465.HKD","JDOC","IE00BWXC8680.SGD","IE00BFTCPJ56.SGD","LU1548497426.USD","IE00B1XK9C88.USD","IE00BJJMRZ35.SGD","LU0432979614.USD","LU0109394709.USD","LU1623119135.USD","LU0316494557.USD","LU0203202063.USD","LU2236285917.USD","RXL","LU0345770993.USD","FHLC","LLYX","LU0353189763.USD","LU2168564149.EUR","LU0234572021.USD","LU2361044949.HKD","LU2237443978.SGD","SG9999018865.SGD","SGXZ81514606.USD","SG9999017495.SGD","LU0385154629.USD","LU2087625088.SGD","LU1280957306.USD","LU2746668974.SGD","LU2756315318.SGD","VHT","LU1366192091.USD","THNR","LU0097036916.USD","IE00BKDWB100.SGD","LU0061475181.USD","LU0882574139.USD","LU1868836757.USD","LU2211815571.USD","LU2750360997.AUD","SG9999014914.USD","LU1868836591.USD","IE00B2B36J28.USD","LU1712237335.SGD","LU0466842654.USD","MEDX","LU0786609619.USD","LU1267930730.SGD","LU0198837287.USD","IE00BFSS7M15.SGD","LU0289739699.SGD","LU2471134952.CNY","LU0353189680.USD","LU2552382058.USD","ELIL","SG9999014880.SGD","IE00BK4W5M84.HKD","LU0238689110.USD","LU0158827948.USD","LU0203201768.USD","LU0106261372.USD","LU1057294990.SGD","TRUH","LU0820561818.USD","LU1868837136.USD","LU0823416689.USD","LU2360106947.USD","LU2552382132.HKD","SGXZ99366536.SGD","LU2089283258.USD","LU1629891620.HKD","SG9999015945.SGD","IYH","LU0006306889.USD","IE0001KFT4U8.USD","LU0889565916.HKD","LU1323610961.USD","LU1064131342.USD","BK4533","LU0158827781.USD","FHTX","LU0210536198.USD","LU1720051108.HKD","LU1979441026.SGD","LU1989771016.USD","LU0471298777.SGD","LU2456880835.USD","LLII","LU0471298694.HKD","LLY","LU1814569148.SGD","LU2552382215.SGD","LU0787776722.HKD","MHIP","OZEM","LU2213496289.HKD","LU2028103732.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672675483","title":"Jefferies Adjusts Price Target on Merck & Co to $177 From $175, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2672675483","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672675483?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:35","pubTimestamp":1790854529,"startTime":"0","endTime":"0","summary":"Merck & Co (MRK) has an average rating of overweight and mean price target of $154.84, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major b","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BN8TJ469.HKD","LU2125154778.USD","BK4534","LU0965509283.SGD","LU2023250843.SGD","LU0072461881.USD","LU2491050154.USD","LU2461242641.AUD","IE00B1BXHZ80.USD","LU0320765646.SGD","IE00BBT3K403.USD","BK4516","LU0823416689.USD","LU0648001328.SGD","LU1093756168.USD","LU1974910355.USD","LU0265550359.USD","IE00BJJMRZ35.SGD","LU0234572021.USD","SG9999013999.USD","SG9999001176.SGD","LU0868494617.USD","LU0162691827.USD","SGXZ57979304.SGD","LU2491050071.SGD","LU2357627491.SGD","LU0266013472.USD","LU1066051498.USD","LU0985320562.USD","SG9999002232.USD","LU0106261372.USD","LU2106854487.HKD","LU2125909593.SGD","FHLC","LU1116320901.HKD","LU1066051225.USD","LU1037948541.HKD","LU0130102774.USD","IE00BLSP4239.USD","IE00B4R5TH58.HKD","LU0203347892.USD","LU1162221912.USD","LU1571399168.USD","TRUH","LU0098860793.USD","IE00BFTCPJ56.SGD","LU1934455194.USD","LU0432979614.USD","VHT","LU0965509010.AUD","BK4550","IE000M9KFDE8.USD","LU0859254822.USD","LU1941712348.USD","IHE","LU0265550946.USD","LU0965509101.SGD","LU1057294990.SGD","LU1585245621.USD","LU1066051811.HKD","LU0861579265.USD","LU0203345920.USD","SG9999001176.USD","LU0289961442.SGD","SG9999015341.SGD","LU0122379950.USD","PAWZ","LU1035773651.USD","LU0124676726.USD","LU0069063385.USD","BK4588","LU1989772840.SGD","LU0057025933.USD","IE00BSNM7G36.USD","LU1023059063.AUD","IE0009355771.USD","JDOC","IE00B2B36J28.USD","LU2468319806.SGD","LU1037948897.HKD","MRK","LU2023250504.SGD","LU2125154935.USD","LU0238689110.USD","IE00BLSP4452.SGD","LU0208291251.USD","LU0689626769.HKD","SG9999014575.USD","LU1291159041.SGD","LU1923622614.USD","LU0965508806.USD","LU2361044865.SGD","LU1983299246.USD","LU2360032135.SGD","LU0289739699.SGD","SG9999014542.SGD","HRTS","LU0006306889.USD","IXJ","LU1929549753.HKD","LU2089984988.USD","LU1066053197.SGD","LU0477156953.USD","IE00BJT1NW94.SGD","LU0211331839.USD","LU0980610538.SGD","LU0289739343.SGD","LU0868494708.USD","LU1069347547.HKD","LU2361045086.USD","SG9999014567.USD","XLV","LU1032466523.USD","LU2433249047.HKD","GDOC","LU2112291526.USD","LU1201861249.SGD","LU1941712264.USD","LU1093756325.SGD","LU0472753341.HKD","RXL","LU0511384066.AUD","BK4585","LU2324357040.USD","LU2491049909.HKD","FTXH","BMED","SG9999001440.SGD","IYH","LU0130517989.USD","IE0002141913.USD","LU0320765489.SGD","LU1699723380.USD","SG9999015358.SGD","LU0058720904.USD","LU1934455863.HKD","BK4533","LU1116320737.USD","LU1061106388.HKD","BK4007","LU0070302665.USD","LU2361044949.HKD","PPH","LU2125909247.SGD","BK4559","LU1917777945.USD","LU1430594728.SGD","SG9999002224.SGD","SG9999014559.SGD","LU1934455277.USD","LU1989771016.USD","LU1989772923.USD","LU0942090050.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672751709","title":"InflaRx Appoints Gabriela Alperovich as SVP, Global Head of Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2672751709","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672751709?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:31","pubTimestamp":1790854303,"startTime":"0","endTime":"0","summary":"InflaRx appoints Gabriela Alperovich as SVP, global head of clinical developmentInflaRx appointed Gabriela Alperovich as senior vice president and global head of clinical development, effective Oct. 1","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL9m1r3P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHLC","IFRX","XLV","PPH","LU2596442595.SGD","IXJ","JDOC","AGNG","LU0321505868.SGD","LU0198837287.USD","FTXH","LU0795875169.SGD","IE00BQXX3F31.USD","VHT","LU1236620834.HKD","LU0225284248.USD","LU2242652126.USD","BK4532","LU0314104364.USD","LU2112291526.USD","LU2125909247.SGD","LU2347655073.USD","LU0820561818.USD","IHE","LU1093756168.USD","LU2237443549.SGD","IYH","LU1868837300.USD","LU1670628061.USD","LU0949170772.SGD","LU1496350171.SGD","RXL","IE00BSNM7G36.USD","ABBV","LU2237443465.HKD","LU2242646821.SGD","NDAQ","GLAM","BK4533","MEDX","LU1061106388.HKD","BCDF","LU2210149790.SGD","PJP","LU0823416689.USD","IE000BZT7R73.USD","BMY","CSL.AU","LU0882574055.USD","TRUH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672751840","title":"Lilly Says Foundayo Cuts Predicted 10-Year Type 2 Diabetes Risk 57% in Attain-1 Post-Hoc Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2672751840","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672751840?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:04","pubTimestamp":1790852676,"startTime":"0","endTime":"0","summary":"Lilly says Foundayo cuts predicted 10-year type 2 diabetes risk 57% in ATTAIN-1 post-hoc analysisEli Lilly disclosed post-hoc analyses from its Phase 3 ATTAIN-1 trial; findings were published in Diabe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDLbmlv0g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","IE00B4R5TH58.HKD","MEDX","LU2264538146.SGD","IE00BJJMRX11.SGD","LU2750360641.GBP","LLYX","LU1623119135.USD","LU2023250330.USD","LLII","LU0820561909.HKD","LU2361044865.SGD","SGXZ57979304.SGD","CANC","LU0466842654.USD","SG9999015952.SGD","LU1988902786.USD","LU2168564222.USD","LU2361044949.HKD","LU0708995401.HKD","LU1232071149.USD","IYH","LU0943347566.SGD","SG9999001176.SGD","SG9999015978.USD","BK4007","LU2106854487.HKD","TMED","IE00B4JS1V06.HKD","LU2237443382.USD","IE00B2B36J28.USD","LU0256863902.USD","LU1057294990.SGD","LU1064131342.USD","LU1989771016.USD","LU2471134523.USD","LU2552382132.HKD","LU1868836591.USD","JDOC","IE00BK4W5M84.HKD","IE00BKDWB100.SGD","LU0882574139.USD","LU2462591350.SGD","LU0061475181.USD","SGXZ51526630.SGD","LU0823434740.USD","WDNA","LU2063271972.USD","SG9999014906.USD","LU2237443465.HKD","LU2471134952.CNY","LU1868837136.USD","THNR","LU2750360997.AUD","IE00BN29S564.USD","SG9999017495.SGD","LU0097036916.USD","LU2417539215.USD","BK4533","LU1093756168.USD","LU2361045086.USD","PPH","LU0353189680.USD","IE00BJJMRY28.SGD","LU0354030511.USD","LU0106261372.USD","LU0238689110.USD","OZEM","LU1023059063.AUD","LU2471134879.HKD","ELIL","IE0002141913.USD","IE00BFTCPJ56.SGD","LU0964807845.USD","BK4599","LU0683600562.USD","LU0432979614.USD","IE00BWXC8680.SGD","LU1720051017.SGD","LU0820562030.AUD","LU1868837300.USD","LU2456880835.USD","LU0225283273.USD","IE0004445239.USD","LU2491050154.USD","LU2552382058.USD","FHLC","LU1291159041.SGD","LU2471134796.USD","BK4516","LU1551013425.SGD","LU2357305700.SGD","LU1868836757.USD","LU2111349929.HKD","LU2087625088.SGD","LU2168564495.EUR","LU0640476718.USD","LU0094547139.USD","LU1127390331.HKD","LU2265009873.SGD","LU2237443622.USD","IE0009355771.USD","LU2746668461.USD","LU2896262040.SGD","ELIS","IE00BFSS8Q28.SGD","LU2756315664.SGD","TRUH","LU2023251221.USD","LU0320765992.SGD","LU0323591593.USD","IE0001KFT4U8.USD","SG9999014914.USD","LU1280957306.USD","LU2462157665.USD","LU2089984988.USD","LU2168564149.EUR","CURE","IXJ","LU1035775433.USD","LU0689472784.USD","IE0004445015.USD","LU2756315318.SGD","LU2237443895.HKD","SG9999001176.USD","LU0234572021.USD","LU2552382215.SGD","LU1917777945.USD","LU0174119429.USD","LU0096364046.USD","LU2236285917.USD","LU1868836914.USD","LU2237443978.SGD","LU0471298694.HKD","LU0385154629.USD","LU0823416689.USD","MEDI","SG9999018865.SGD","LU0203201768.USD","LU0256863811.USD","LU0786609619.USD","LU2213496289.HKD","IE00B7KXQ091.USD","LU1551013342.USD","LU1629891620.HKD","LU0109391861.USD","LU1691799644.USD","LU1712237335.SGD","SG9999013999.USD","LU0158827948.USD","LU0820561818.USD","LU1061106388.HKD","LU0058720904.USD","LU0353189763.USD","LU0354030438.USD","MHIP","HRTS","LU0456855351.SGD","LU1814569148.SGD","LU1093756325.SGD","LU2237443549.SGD","XLV","LU1979441026.SGD","LU1974910355.USD","LU0133085943.USD","RXL","LU2168563687.JPY","LU1323610961.USD","LU1366192091.USD","SG9999014880.SGD","LU0203202063.USD","LU0471298777.SGD","GB00BDT5M118.USD","LU2491049909.HKD","LU0823434583.USD","BK4585","IE00BJT1NW94.SGD","LU0266013472.USD","SG9999015986.USD","IE00BK4W5L77.USD","LU2360106947.USD","ILDR","LU1267930730.SGD","IHE","LU0006306889.USD","LU2108987350.USD","LU2089284900.SGD","LU0122379950.USD","LU2237438978.USD","LU2324357040.USD","IE00B1XK9C88.USD","LU0787776722.HKD","LU2468319806.SGD","GDOC","LU1069344957.HKD","LU1548497426.USD","LU2271345857.HKD","LU2602419157.SGD","LU2461242641.AUD","LU0289739699.SGD","LU2746668974.SGD","SGXZ31699556.SGD","LU0672654240.SGD","IE00BFSS7M15.SGD","LU0882574055.USD","IE00BJLML261.HKD","IE00BJJMRZ35.SGD","LU1804176565.USD","FTXH","LU2112291526.USD","IE00B775H168.HKD","LU2023250504.SGD","SG9999018857.SGD","IE00BKPKM429.USD","IE00B1BXHZ80.USD","LU2211815571.USD","LU0079474960.USD","IE0005OL40V9.USD","LU1720051108.HKD","LU0345770993.USD","PJP","BK4588","LU0210536198.USD","LU0417517546.SGD","LU0158827781.USD","LU2028103732.USD","LU1983299246.USD","SGXZ99366536.SGD","LU2089283258.USD","SG9999015945.SGD","VHT","LU0345770308.USD","LU1145028129.USD","AGNG","SG9999014898.SGD","SGXZ81514606.USD","LU0316494557.USD","LU0109394709.USD","LLY","BK4581","LLYZ","LU0114720955.EUR","LU0320765059.SGD","LU2491050071.SGD","LU0198837287.USD","LU2168564065.EUR","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672759093","title":"Eli Lilly - Foundayo 17.2 Mg Associated with 57% Reduction in Diabetes Risk, 18% in Cardiovascular Risk Versus Placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2672759093","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672759093?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:01","pubTimestamp":1790852493,"startTime":"0","endTime":"0","summary":"BRIEF-Eli Lilly - Foundayo 17.2 Mg Associated With 57% Reduction In Diabetes Risk, 18% In Cardiovascular Risk Versus PlaceboOct 1 (Reuters)-Eli Lilly and CompanyLLY.N:ELI LILLY - FOUNDAYO 17.2 MG ASSO","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45N0OB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443549.SGD","GDOC","JDOC","LU0234572021.USD","LU0354030511.USD","LU2089284900.SGD","LU2168564065.EUR","LU0323591593.USD","LU2213496289.HKD","LU2750360997.AUD","BK4007","LU0114720955.EUR","SGXZ51526630.SGD","SG9999014898.SGD","LU0203201768.USD","LU2491050071.SGD","IE00B1BXHZ80.USD","IE00BJJMRX11.SGD","LU0456855351.SGD","LU0683600562.USD","LU2023250330.USD","SG9999014906.USD","IE0009355771.USD","LU2271345857.HKD","LU1280957306.USD","LU2237443465.HKD","LU2471134879.HKD","MEDI","IE00B7KXQ091.USD","GB00BDT5M118.USD","BK4581","LU0320765059.SGD","LU1035775433.USD","LU2746668461.USD","LU2168564495.EUR","IE00BK4W5M84.HKD","LU2236285917.USD","LU2471134952.CNY","LU2108987350.USD","LU0096364046.USD","LU0689472784.USD","LU0820561909.HKD","LU2087625088.SGD","IE0004445015.USD","LU0094547139.USD","LU2211815571.USD","LU2456880835.USD","BK4516","LU1691799644.USD","LU2112291526.USD","LU1366192091.USD","SG9999018865.SGD","LU2491049909.HKD","LU0385154629.USD","LU0345770308.USD","LU1548497426.USD","SG9999013999.USD","LU0316494557.USD","LU1069344957.HKD","LU1629891620.HKD","IE00B1XK9C88.USD","CURE","LU0466842654.USD","LU2361045086.USD","LU1983299246.USD","IE0001KFT4U8.USD","ELIS","LU0266013472.USD","LU1267930730.SGD","LU0109391861.USD","LU1551013425.SGD","LU1974910355.USD","LU2265009873.SGD","IE00BFTCPJ56.SGD","LU2491050154.USD","LU0158827781.USD","TMED","LU0106261372.USD","LU0225283273.USD","LU2461242641.AUD","LU1868836757.USD","LU0417517546.SGD","LU0353189680.USD","LU1804176565.USD","LU1712237335.SGD","LU2023251221.USD","PJP","LU0133085943.USD","IYH","LU2462157665.USD","VHT","LU0210536198.USD","BK4534","LU2471134523.USD","LU0320765992.SGD","LU0061475181.USD","IE00BWXC8680.SGD","LU0238689110.USD","LU2111349929.HKD","LU1064131342.USD","LU0122379950.USD","IE00BJJMRY28.SGD","PPH","LU2896262040.SGD","LU0345770993.USD","LLYZ","ELIL","LU2756315664.SGD","LU2417539215.USD","LU0889565916.HKD","BK4533","LU0882574139.USD","IE00BFSS8Q28.SGD","LU2237443978.SGD","LU2552382215.SGD","IE00BN29S564.USD","LU0289739699.SGD","THNR","LU0672654240.SGD","CANC","XLV","LU0823434740.USD","LLY","LU1127390331.HKD","LU2168563687.JPY","IHE","LU0820562030.AUD","LU0203202063.USD","LU1023059063.AUD","IE0004445239.USD","IE00BKDWB100.SGD","LU0820561818.USD","LU0471298777.SGD","MEDX","FHLC","LU0097036916.USD","LU0006306889.USD","LU0079474960.USD","LU0158827948.USD","LU1979441026.SGD","SGXZ31699556.SGD","LU2237443895.HKD","LU2462591350.SGD","LU2360106947.USD","LU0256863811.USD","LU1061106388.HKD","LLII","LU0943347566.SGD","LU2168564222.USD","LU2357305700.SGD","WDNA","LU0882574055.USD","IE00BJT1NW94.SGD","LU1232071149.USD","SG9999015952.SGD","SG9999014880.SGD","AGNG","BK4599","LU0353189763.USD","LU2468319806.SGD","LU1814569148.SGD","HRTS","RXL","LU2028103732.USD","LU1057294990.SGD","LU1551013342.USD","IE00B4JS1V06.HKD","LU2063271972.USD","LU2089283258.USD","SG9999014914.USD","LU2023250504.SGD","LU0354030438.USD","LU2237443622.USD","IE00B4R5TH58.HKD","LU0640476718.USD","LU1868837136.USD","LU2471134796.USD","BK4585","LU0256863902.USD","LU1623119135.USD","LU1868837300.USD","LU2750360641.GBP","LU0198837287.USD","BK4588","LU2552382132.HKD","IE0002141913.USD","IE0005OL40V9.USD","LU1989771016.USD","SGXZ57979304.SGD","SG9999015945.SGD","LU1868836914.USD","SGXZ99366536.SGD","LU1093756168.USD","LU1868836591.USD","OZEM","LU2756315318.SGD","IE00B2B36J28.USD","LU2237438978.USD","LU0058720904.USD","ILDR","IXJ","LU1291159041.SGD","LU2361044865.SGD","LU1720051108.HKD","LU2168564149.EUR","TRUH","LU0823416689.USD","LU2106854487.HKD","IE00BKPKM429.USD","LU2324357040.USD","LU2602419157.SGD","SG9999015986.USD","LU0471298694.HKD","LU2746668974.SGD","SG9999017495.SGD","SG9999015978.USD","LU2552382058.USD","LU0787776722.HKD","LU1720051017.SGD","LU1323610961.USD","LU0708995401.HKD","IE00BJLML261.HKD","LU0109394709.USD","LU0174119429.USD","LU1093756325.SGD","LU1988902786.USD","IE00BJJMRZ35.SGD","MHIP","SG9999001176.SGD","LU0786609619.USD","LU1917777945.USD","FTXH","SG9999001176.USD","LU0964807845.USD","SG9999018857.SGD","LU0823434583.USD","LLYX","LU2089984988.USD","LU2237443382.USD","LU2361044949.HKD","IE00B775H168.HKD","SGXZ81514606.USD","IE00BK4W5L77.USD","LU1145028129.USD","IE00BFSS7M15.SGD","LU2264538146.SGD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":16,"pageCount":2,"totalSize":305,"code":"91000000","status":"200"}]}}